Pharmacokinetic and pharmacodynamic profile of bendamustine and its metabolites

por Darwish, Mona, Bond, Mary, Hellriegel, Edward, Robertson, Philmore, Chovan, James P.
Publicado 2015

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study

por Gordon, David, Hellriegel, Edward T, Hope, Heidi Rath, Burt, David, Monahan, Joseph B
Publicado 2021

An evaluation of the potential for drug–drug interactions between bendamustine and rituximab in indolent non-Hodgkin lymphoma and mantle cell lymphoma

por Darwish, Mona, Burke, John M., Hellriegel, Edward, Robertson, Philmore, Phillips, Luann, Ludwig, Elizabeth, Munteanu, Mihaela C., Bond, Mary
Publicado 2014

Pharmacokinetic and Metabolic Profile of Deutetrabenazine (TEV‐50717) Compared With Tetrabenazine in Healthy Volunteers

por Schneider, Frank, Bradbury, Margaret, Baillie, Thomas A., Stamler, David, Hellriegel, Edward, Cox, Donna S., Loupe, Pippa S., Savola, Juha‐Matti, Rabinovich‐Guilatt, Laura
Publicado 2020

Pharmacokinetics of Deutetrabenazine and Tetrabenazine: Dose Proportionality and Food Effect

por Schneider, Frank, Stamler, David, Bradbury, Margaret, Loupe, Pippa S., Hellriegel, Edward, Cox, Donna S., Savola, Juha‐Matti, Gordon, Mark Forrest, Rabinovich‐Guilatt, Laura
Publicado 2020

Pharmacokinetics and Excretion of (14)C-Bendamustine in Patients with Relapsed or Refractory Malignancy

por Dubbelman, Anne-Charlotte, Rosing, Hilde, Darwish, Mona, D’Andrea, Denise, Bond, Mary, Hellriegel, Edward, Robertson, Philmore, Beijnen, Jos H., Schellens, Jan H. M.
Publicado 2013

Pharmacokinetics and excretion of (14)C-omacetaxine in patients with advanced solid tumors

por Nijenhuis, Cynthia M., Hellriegel, Edward, Beijnen, Jos H., Hershock, Diane, Huitema, Alwin D. R., Lucas, Luc, Mergui-Roelvink, Marja, Munteanu, Mihaela, Rabinovich-Guilatt, Laura, Robertson, Philmore, Rosing, Hilde, Spiegelstein, Ofer, Schellens, Jan H. M.
Publicado 2016

Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicenter, open-label, single-arm, phase 3 study

por Shi, Yuan-Kai, Hong, Xiao-Nan, Yang, Jian-Liang, Xu, Wei, Huang, Hui-Qiang, Xiao, Xiu-Bin, Zhu, Jun, Zhou, Dao-Bin, Han, Xiao-Hong, Wu, Jian-Qiu, Zhang, Ming-Zhi, Jin, Jie, Ke, Xiao-Yan, Li, Wei, Wu, De-Pei, Yang, Shen-Miao, Du, Xin, Jia, Yong-Qian, Liu, Ai-Chun, Liu, Dai-Hong, Shen, Zhi-Xiang, Zhang, Lian-Sheng, James, Leonard, Hellriegel, Edward
Publicado 2021